MaxCyte (MXCT) Insider Trading & Ownership GBX 345 +2.00 (+0.58%) (As of 11:40 AM ET) Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsHeadlinesInsider Trades MaxCyte (LON:MXCT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage1.45%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)2Amount OfInsider Selling(Last 12 Months)£207,083.32 Get MXCT Insider Trade Alerts Want to know when executives and insiders are buying or selling MaxCyte stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address MXCT Insider Buying and Selling by Quarter Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now MaxCyte Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails10/2/2024Stan ErckInsiderSell47,689GBX 388£185,033.323/26/2024John JohnstonInsiderSell5,000GBX 441£22,050 (Data available from 1/1/2013 forward) MXCT Insider Trading Activity - Frequently Asked Questions Who is on MaxCyte's Insider Roster? The list of insiders at MaxCyte includes Doug Doerfler, John Johnston, and Stan Erck. Learn more on insiders at MXCT. What percentage of MaxCyte stock is owned by insiders? 1.45% of MaxCyte stock is owned by insiders. Learn more on MXCT's insider holdings. Which MaxCyte insiders have been selling company stock? The following insiders have sold MXCT shares in the last 24 months: Doug Doerfler (£446,770.32), John Johnston (£23,522.40), and Stan Erck (£185,033.32). How much insider selling is happening at MaxCyte? Insiders have sold a total of 141,890 MaxCyte shares in the last 24 months for a total of £655,326.04 sold. MaxCyte Key ExecutivesMr. Maher Masoud (Age 48)President, CEO, Secretary & Director Compensation: $484.7kMr. Douglas Arthur Doerfler (Age 68)Founder Compensation: $950.01kMr. Douglas J. Swirsky CFA (Age 55)CPA, Chief Financial Officer Mr. Jay GelfmanSenior Vice President of OperationsMr. Ronald Evan Holtz CPA (Age 66)Ph.D., Executive Vice President of Administration Compensation: $514.26kMr. Sean MenarguezDirector of Investor RelationsMr. David SandovalSenior Vice President & General CounselMr. Thomas Michael Ross (Age 63)Executive Vice President of Global Sales Mr. Jack HorganVice President of Corporate DevelopmentMs. Jill MayerSenior Vice President of Human Resources More Insider Trading Tools from MarketBeat Related Companies Herald Insider Buying PayPoint Insider Buying Ocean Wilsons Insider Buying Chesnara Insider Buying Tremor International Insider Buying Accrol Group Insider Buying TruFin Insider Buying Staffline Group Insider Buying Creightons Insider Buying FireAngel Safety Technology Group Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (LON:MXCT) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredThis drone stock is setting up to transform medical supply deliveryDrone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks.The Tomorrow Investor | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MaxCyte, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MaxCyte With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MXCT Stock Alerts